Takeki Sugimoto

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients

Takehiro Okabayashi, Yasuo Shima, Tatsuaki Sumiyoshi et al. · Diabetes Care · 2014 · 113 citations · Full text

Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study

Kengo Ichikawa, Takehiro Okabayashi, Hiromichi Maeda et al. · Surgery Today · 2012 · 71 citations

Early Recurrence, Hepatology, Medicine +13

Effects of branched‐chain amino acids–enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma

Takehiro Okabayashi, Isao Nishimori, Takeki Sugimoto et al. · Journal of Gastroenterology and Hepatology · 2008 · 69 citations

Clinicopathological features and medical management of intraductal papillary mucinous neoplasms

Takehiro Okabayashi, Michiya Kobayashi, Isao Nishimori et al. · Journal of Gastroenterology and Hepatology · 2006 · 67 citations